Medicine and Dentistry
Premature Labor
100%
Uterine Cancer
99%
Ovarian Cancer
92%
Neoplasm
91%
Diseases
81%
Cesarean Section
78%
Pregnancy
71%
Malignant Neoplasm
61%
Gynecological Oncology
56%
Odds Ratio
54%
Cancer
48%
Cervical Cancer
44%
Pelvis
41%
Pre-Eclampsia
39%
Oncology
38%
Overall Survival
38%
Obstetrics
38%
Krukenberg Tumor
34%
Gestational Age
33%
Human Immunodeficiency Virus
32%
Recurrent Disease
32%
Infection
31%
Colposcopy
30%
First Trimester Pregnancy
30%
Placenta
30%
Randomized Controlled Trial
30%
Systematic Review
29%
Body Mass Index
28%
Endometrium Carcinoma
28%
Health Care Cost
28%
Oocyte
27%
Wart Virus
27%
Retrospective Cohort Study
26%
Meta-Analysis
26%
Vaginal Delivery
26%
Fetus Growth
25%
Amnion Fluid
25%
Bladder
25%
Endometriosis
24%
Logistic Regression Analysis
23%
Adolescence
23%
Radiation Therapy
23%
Progression Free Survival
22%
Vaginal Birth after Cesarean
22%
Surgery
22%
Hysterectomy
21%
Newborn Morbidity
21%
Neonate
20%
Small for Gestational Age
20%
Carcinoma
20%
Metastatic Carcinoma
20%
In Vitro Fertilisation
20%
Clinician
20%
Cytotechnology
19%
Cervix
19%
Intrauterine Growth Retardation
19%
Biopsy Technique
19%
Female Genital Tract Cancer
18%
Birth Weight
18%
Second Trimester Pregnancy
18%
Paclitaxel
17%
Bleeding
17%
Cervical Intraepithelial Neoplasia
17%
Counseling
17%
Diagnosis
16%
Clinical Trial
16%
Gynecology
16%
Programmed Cell Death
16%
Maternal Morbidity
16%
Prevalence
15%
Magnetic Resonance Imaging
15%
Hazard Ratio
15%
Intrapartum
15%
Assisted Reproductive Technology
15%
Biological Marker
15%
Intrauterine Device
15%
Cancer Cell
15%
Papanicolaou Stain
15%
Endometrium
15%
In Vitro
15%
Pelvic Organ Prolapse
14%
Umbilical Artery
14%
Blastocyst
14%
Prematurity
14%
Disease
14%
Microsatellite Instability
14%
Cervical Cancer Screening
14%
Quality of Life
14%
Stillbirth
14%
Twin Pregnancy
13%
Echography
13%
Cisplatin
13%
Chorioamnionitis
13%
Pelvic Floor
13%
Urinary Tract Infection
13%
Fetus Monitoring
13%
Nulliparous
13%
Fallopian Tube
13%
COVID-19
13%
Diabetes
13%
Keyphrases
Confidence Interval
94%
Endometrial Cancer
80%
Ovarian Cancer
71%
Tumor
59%
Preterm Birth
55%
Fetus
51%
Preterm Labor
48%
Cervical Cancer
44%
Cesarean Delivery
43%
Preeclampsia
41%
Pregnant Women
40%
Gynecologic Oncology Group
39%
Overall Survival
37%
NRG Oncology
36%
Placenta
34%
Risk Factors
32%
United States
30%
Chemotherapy
30%
During Pregnancy
30%
Endometriosis
29%
Randomized Controlled Trial
29%
Obesity
29%
Extravillous Trophoblast
29%
Colposcopy
29%
Adverse Pregnancy Outcomes
29%
Gestational Age
28%
Adjusted Odds Ratio
28%
Group Studies
27%
High Risk
27%
Amniotic Fluid
26%
Odds Ratio
26%
Meta-analysis
25%
Retrospective Cohort Study
24%
Apoptosis
24%
Vaginal Birth
23%
Trophoblast
23%
Body Mass Index
23%
Neonatal Morbidity
23%
Pregnancy Outcome
22%
Infertility
22%
Neonatal Outcome
22%
Endometrial Carcinoma
22%
Spontaneous Preterm Birth (sPTB)
22%
First Trimester
22%
AIDS/HIV
21%
Ultrasound
20%
Systematic Meta-analysis
20%
Progression-free Survival
20%
Preterm Delivery
20%
Small-for-gestational Age
20%
Long-acting Reversible Contraception
20%
High-risk Human Papillomavirus (HR-HPV)
19%
In Vitro Fertilization
19%
Gynecologic Oncology
19%
Hysterectomy
19%
Whole Genome
19%
Selective Intrauterine Growth Restriction (sIUGR)
19%
Uterus
19%
Cisplatin
19%
Obstetrics and Gynaecology
18%
Cervical Intraepithelial Neoplasia
17%
Microsatellite Instability-high (MSI-H)
17%
Cervical Carcinoma
17%
Week of Gestation
17%
Ovarian Cancer Patients
17%
Hazard Ratio
17%
Epithelial Ovarian Cancer
17%
Neonate
17%
Induction of Labor
17%
Contraceptives
16%
Twin-twin Transfusion Syndrome
16%
Pan-cancer Analysis
16%
Relative Risk
16%
Inflammation
16%
Fetal Growth Restriction
16%
Paclitaxel
16%
Ovarian Cancer Cells
16%
Intrauterine Inflammation
16%
Obese Women
16%
Second Trimester
15%
Cervical Cancer Screening
15%
Singleton Pregnancy
15%
Radiation Therapy
15%
Recurrent Endometrial Cancer
15%
Birth Weight
15%
Human Placenta
15%
Intra-amniotic Infection
15%
Adverse Neonatal Outcome
15%
Vaginal Delivery
14%
Endometrial Stromal Cells
14%
Gynecologic Malignancies
14%
Randomized Trial
14%
Glucose Transporter 1 (GLUT1)
14%
Gene Expression
14%
Gynecological Cancer
14%
Bevacizumab
14%
COVID-19
14%
Preterm Premature Rupture of Membranes (PPROM)
13%
Urinary Tract Infection
13%
Hypoxia
13%